Topic
Future therapeutic strategies for obesity.
Mechanistic Frontier
Obesity involves dysregulation of appetite control, energy expenditure,
and adipose tissue biology. Major validated pathways include CNS appetite
regulation through incretin signaling, adipose inflammation, and metabolic
signals from the gut microbiome.
Key Uncertainty Nodes
• Durability and safety of CNS-targeted obesity drugs
• Translational impact of brown adipose tissue activation
• Causal metabolic role of microbiome interventions
Decisive Experiments
• Long-term incretin therapy studies with deep metabolic phenotyping
• Human BAT activation trials measuring energy expenditure
• Controlled microbiome metabolite intervention studies
Strategic Pathways
1. Next-generation CNS appetite modulation therapies
2. Brown / beige adipose tissue activation programs
3. Mechanistic microbiome metabolic interventions
Opportunity Ranking
1. CNS-targeted therapeutics – highest feasibility
2. BAT activation – emerging opportunity
3. Microbiome interventions – high uncertainty